UBS lowered the firm’s price target on Danaher (DHR) to $225 from $240 and keeps a Buy rating on the shares. Danaher reported an in-line Q2, but Q3 guidance was slightly below estimates, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DHR:
- Danaher call buyer realizes 36% same-day gains
- Danaher price target raised to $229 from $226 at Baird
- Danaher price target lowered to $205 from $210 at Wells Fargo
- Balanced Outlook for Danaher: Solid Earnings Beat Amidst Cautious Guidance and Mixed Segment Performance
- Danaher: Strong Q2 Performance and Growth Potential Justify Buy Rating